SUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmace
Recalled January 21, 2026 · FDA recall D-0257-2026 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. · FDA Class III
Sold at
Nationwide in the USA.
Description
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
Product
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →